India Glycols Limited Schedules Q4 & Full Year FY26 Earnings Conference Call for May 18, 2026

1 min read     Updated on 07 May 2026, 11:17 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

India Glycols Limited has announced a Q4 & Full Year FY26 Earnings Conference Call on Monday, May 18, 2026, at 16:00 Hrs IST, organised by InCred Equities. Senior officials including CEO Mr. Rupark Sarswat and CFO Mr. Anand Singhal will participate. The disclosure was made under SEBI Regulation 30, with dial-in access available for investors across India, USA, UK, Singapore, and Hong Kong.

powered bylight_fuzz_icon
39720835

*this image is generated using AI for illustrative purposes only.

India Glycols Limited has announced an Earnings Conference Call to discuss its financial results for Q4 and Full Year FY26. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated to both BSE Limited and the National Stock Exchange of India Limited on 7th May, 2026.

Conference Call Details

The Earnings Conference Call is scheduled for Monday, May 18, 2026, at 16:00 Hrs IST. The following table summarises the key details of the event:

Parameter: Details
Event: Q4 & Full Year FY26 Earnings Conference Call
Date: Monday, May 18, 2026
Time: 16:00 Hrs IST
Organised by: InCred Equities

Company Participants

The following senior officials of India Glycols Limited are scheduled to participate in the conference call:

  • Mr. Rupark Sarswat – Chief Executive Officer
  • Mr. Anand Singhal – Chief Financial Officer
  • Mr. S.K. Shukla – Head, Liquor Business
  • Mr. Ankur Jain – Head (Legal) & Company Secretary

Dial-In Information

Investors and analysts can join the call using the following dial-in details:

Region: Dial-In Number
India (Universal): +91 22 6280 1527
India (Universal): +91 22 7115 8322
USA (International Toll Free): 18667462133
UK (International Toll Free): 08081011573
Singapore (International Toll Free): 8001012045
Hong Kong (International Toll Free): 800964448

For any enquiries regarding the conference call, participants may contact InCred Equities at silketha.quinny@incredresearch.com or +91 98923 80170. The InCred Equities team members available for assistance include Nitin Awasthi (+91 22 4161 1550), Satish Kumar (+91 22 4161 1557), and Ajay Rao (+91 99679 50001).

Regulatory Disclosure

The intimation was signed by Ankur Jain, Head (Legal) & Company Secretary of India Glycols Limited, and has also been hosted on the company's official website at www.indiaglycols.com . The company is headquartered at Plot No. 2-B, Sector - 126, NOIDA-201304, Distt. Gautam Budh Nagar, Uttar Pradesh.

Historical Stock Returns for India Glycols

1 Day5 Days1 Month6 Months1 Year5 Years
+0.89%+10.40%+28.44%+14.75%+66.17%+357.14%

How might India Glycols' FY26 full-year performance compare to industry peers in the specialty chemicals and glycols sector amid fluctuating raw material costs?

What strategic expansion plans or capital allocation decisions could India Glycols announce for FY27 following the release of its Q4 results?

How is the company's liquor business segment expected to evolve given regulatory changes in state-level alcohol policies across India?

India Glycols Limited Notifies NCLT Scheme Petition Hearing Scheduled for May 21, 2026

2 min read     Updated on 06 May 2026, 07:05 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

India Glycols Limited has submitted newspaper clippings to BSE and NSE under Regulation 30 of SEBI LODR Regulations, 2015, regarding the Notice of Hearing of its Scheme of Arrangement petition before the NCLT Allahabad Bench, Prayagraj. The petition under Sections 230 to 232 of the Companies Act, 2013, involves a demerger of India Glycols Limited into two resulting companies — Ennature Bio Pharma Limited and IGL Spirits Limited — with the hearing scheduled for May 21, 2026, following NCLT admission on April 9, 2026. The notice was advertised in Financial Express, Business Standard, and Uttar Ujala on May 5, 2026, with Mr. Hirak Mukhopadhyay of Khaitan & Co. acting as Counsel for the Petitioner Companies.

powered bylight_fuzz_icon
39532755

*this image is generated using AI for illustrative purposes only.

India Glycols Limited has filed a disclosure with the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, submitting newspaper clippings related to the Notice of Hearing of the Company Scheme Petition. The hearing before the Hon'ble National Company Law Tribunal (NCLT), Allahabad Bench, Prayagraj, is scheduled for May 21, 2026, as per the directions of the NCLT vide order dated April 9, 2026.

Scheme of Arrangement Details

The petition has been filed under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, read with the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016. The Scheme of Arrangement involves three petitioner companies and their respective shareholders, as detailed below:

Parameter: Details
Petitioner Company 1 / Demerged Company: India Glycols Limited
Petitioner Company 2 / Resulting Company 1: Ennature Bio Pharma Limited
Petitioner Company 3 / Resulting Company 2: IGL Spirits Limited
Case Reference: CP (CAA) No.07/ALD/2026 in CA (CAA) No.36/ALD/2025 (Second Motion)
NCLT Bench: Allahabad Bench, Prayagraj
Order Admission Date: April 9, 2026
Hearing Date: May 21, 2026

Newspaper Advertisement Publication

In compliance with Rule 16 of the Companies (Compromises, Arrangements and Amalgamation) Rules, 2016, the Notice of Hearing was advertised in the following newspapers on May 5, 2026:

  • Financial Express (All Editions) — English
  • Business Standard (All Editions) — English
  • Uttar Ujala (Nainital Edition) — Hindi

Participation and Opposition Process

Any person desirous of supporting or opposing the petition is required to send a notice of intention, signed by themselves or their advocate along with their name and address, to the Advocates for the Petitioner Companies. Such notice must reach the Advocates not later than 7 (seven) days before the date fixed for the hearing, i.e., May 21, 2026. Persons seeking to oppose the petition are required to furnish the grounds of opposition or an affidavit along with the notice.

A copy of the Company Petition filed before the NCLT will be made available to any person requiring the same upon payment of prescribed charges. The Counsel for the Petitioner Companies is Mr. Hirak Mukhopadhyay of Khaitan & Co., Max Towers, 7th and 8th Floors, Sector 16B, Noida, Gautam Buddha Nagar 201 301, U.P.

Regulatory Compliance

The disclosure was made by Ankur Jain, Head (Legal) & Company Secretary of India Glycols Limited, vide letter reference IGL/SE/2026-27/06 dated May 5, 2026, addressed to the Manager (Listing) of BSE Limited and the National Stock Exchange of India Limited. The submission is in accordance with the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for India Glycols

1 Day5 Days1 Month6 Months1 Year5 Years
+0.89%+10.40%+28.44%+14.75%+66.17%+357.14%

How will the demerger of Ennature Bio Pharma Limited and IGL Spirits Limited from India Glycols affect the parent company's revenue streams and long-term growth strategy?

What synergies or competitive advantages are Ennature Bio Pharma Limited and IGL Spirits Limited expected to unlock as independently listed entities post-demerger?

How might the NCLT approval or potential opposition at the May 21, 2026 hearing impact India Glycols' stock valuation and shareholder returns?

More News on India Glycols

1 Year Returns:+66.17%